NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Cognitive deficits associated with frontal lobe dysfunction are a determinant of long-term disability in schizophrenia and are not effectively treated with available medications. Clinical studies show that many aspects of these deficits are transiently induced in healthy individuals treated with N -methyl- d -aspartate (NMDA) antagonists. These findings and recent genetic linkage studies strongly implicate NMDA receptor deficiency in schizophrenia and suggest that reversing this deficiency is pertinent to treating the cognitive symptoms of schizophrenia. Despite the wealth of behavioral data on the effects of NMDA antagonist treatment in humans and laboratory animals, there is a fundamental lack of understanding about the mechanisms by which a general state of NMDA deficiency influences the function of cortical neurons. Using ensemble recording in freely moving rats, we found that NMDA antagonist treatment, at doses that impaired working memory, potentiated the firing rate of most prefrontal cortex neurons. This potentiation, which correlated with expression of behavioral stereotypy, resulted from an increased number of irregularly discharged single spikes. Concurrent with the increase in spike activity, there was a significant reduction in organized bursting activity. These results identify two distinct mechanisms by which NMDA receptor deficiency may disrupt frontal lobe function: an increase in disorganized spike activity, which may enhance cortical noise and transmission of disinformation; and a decrease in burst activity, which reduces transmission efficacy of cortical neurons. These findings provide a physiological basis for the NMDA receptor deficiency model of schizophrenia and may clarify the nature of cortical dysfunction in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex
McCormick, D. A., Connors, B. W., Lighthall, J. W., & Prince, D. A. (1985) · Journal of Neurophysiology · doi:10.1152/jn.1985.54.4.782 · Cited by 1,933
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Self-citationGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Intrinsic firing patterns of diverse neocortical neurons
Connors, B. W., & Gutnick, M. J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90185-d · Cited by 1,448
Research works printed but not linked: 3
- Abel, K. M., Allin, M. P., Kucharska-Pietura, K., David, A., Andrew, C., Williams, S., Brammer, M. J. & Phillips, M. L. (2003) NeuroReport 14, 387-389.12634489
- Grubb, B. D., Riley, R. C., Hope, P. J., Pubols, L. & Duggan, A. W. (1996) Neuroscience 74, 1077-1086.8895876
- Steriade, M., Amzica, F. & Contreras, D. (1994) Electroencephalogr. Clin. Neurophysiol. 90, 1-16.7509269
Cited by
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
“More importantly, our findings provide a clinically relevant mechanism where the resulting hyperactivity of pyramidal neurons (Jackson et al., 2004) and excessive glutamate spillover (Moghaddam et al.”
BackgroundSelf-citationMoghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Self-citationLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
“This has been observed in rodents by electrophysiological methods [60], metabolic imaging methods [61,62] and measurements of glutamate release [63].”
MethodPostnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
“concomitant with an increase in the firing rate of pyramidal neurons in this are”
BackgroundGlutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“Supporting this, preclinical studies show that NMDA blockers such as ketamine and PCP change dopamine synthesis and firing patterns, and increase dopamine release to a challenge such as amphetamine (Balla et al., 2003; Jackson et al., 2004; Miller and Abercrombie, 1996; Tsukada, 2000).”
BackgroundThe Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
Howes, O. D., McCutcheon, R., Owen, M. J., & Murray, R. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.014 · Cited by 601
Neural synchrony indexes disordered perception and cognition in schizophrenia
Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., Shenton, M. E., & McCarley, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406074101 · Cited by 597
Burgos-Robles, A., Vidal-Gonzalez, I., Santini, E., & Quirk, G. J. (2007) · Neuron · doi:10.1016/j.neuron.2007.02.021 · Cited by 523
GABAergic interneuron origin of schizophrenia pathophysiology
Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., & Belforte, J. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.022 · Cited by 498
“First, acute systemic administration of NMDAR antagonists results in hyperactivity of cortical pyramidal neurons (Suzuki et al., 2002; Jackson et al., 2004) and spillover of cortical glutamate (Moghaddam et al., 1997; Lorrain et al., 2003).”
BackgroundWang, M., Yang, Y., Wang, C.-J., Gamo, N. J., Jin, L. E., Mazer, J. A., Morrison, J. H., Wang, X.-J., & Arnsten, A. F. T. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.032 · Cited by 489
“Hyperglutamate theories have arisen from studies of NMDAR actions in rodent PFC, where systemic NMDA antagonists increase neuronal firing and glutamate release (Jackson et al., 2004).”
BackgroundResultInfluentialDisrupted prediction-error signal in psychosis: Evidence for an associative account of delusions
Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R. F., Shanks, D. R., Robbins, T. W., Bullmore, E. T., Dickinson, A., & Fletcher, P. C. (2007) · Brain · doi:10.1093/brain/awm173 · Cited by 460
Dopaminergic and Glutamatergic Regulation of Effort- and Delay-Based Decision Making
Floresco, S. B., Tse, M. T. L., & Ghods-Sharifi, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301565 · Cited by 435
Toward a neurobiology of delusions
Corlett, P. R., Taylor, J. R., Wang, X.-J., Fletcher, P. C., & Krystal, J. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.007 · Cited by 394
Gating multiple signals through detailed balance of excitation and inhibition in spiking networks
Vogels, T. P., & Abbott, L. F. (2009) · Nature Neuroscience · doi:10.1038/nn.2276 · Cited by 381
From drugs to deprivation: A Bayesian framework for understanding models of psychosis
Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1561-0 · Cited by 367
“Jackson and colleagues postulate that the increased random spiking is induced by AMPA receptor stimulation and that decreased burst firing is induced by NMDA receptor blockade (Jackson et al. 2004).”
BackgroundGlutamatergic theories of schizophrenia.
Javitt, D. C. (2010) · PubMed · Cited by 330
Pinault, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.006 · Cited by 315
“It is known that MK-801 and phencyclidine modulate the firing rate in prefrontal cortex neurons (26-27).”
BackgroundNon-Genetic Factors in Schizophrenia
Stilo, S. A., & Murray, R. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1091-3 · Cited by 311
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“hypofunction in PFC may drive disorganized network activity [174].”
BackgroundHong, L. E., Summerfelt, A., Buchanan, R. W., O'Donnell, P., Thaker, G. K., Weiler, M. A., & Lahti, A. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.168 · Cited by 274
“NMDA receptor antagonists increase the spontaneous firing rate of neurons in the medial PFC and nucleus accumbens (NAc) (”
BackgroundGandal, M. J., Edgar, J. C., Klook, K., & Siegel, S. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.007 · Cited by 269
Takahashi, T., Cho, R. Y., Mizuno, T., Kikuchi, M., Murata, T., Takahashi, K., & Wada, Y. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.009 · Cited by 264
Neuroimaging Biomarkers in Schizophrenia
Kraguljac, N. V., McDonald, W. M., Widge, A. S., Rodriguez, C. I., Tohen, M., & Nemeroff, C. B. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20030340 · Cited by 241
Moghaddam, B., & Krystal, J. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs075 · Cited by 238
Self-citationLaviolette, S. R., Lipski, W. J., & Grace, A. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1168-05.2005 · Cited by 235
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Cohen, S. M., Tsien, R. W., Goff, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 232
Glutamatergic model psychoses: prediction error, learning, and inference
Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229
Variable Global Dysconnectivity and Individual Differences in Schizophrenia
Cole, M. W., Anticevic, A., Repovs, G., & Barch, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.010 · Cited by 227
Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V, D'Souza, D. C., Gueorguieva, R., He, G., Ramachandran, R., Suckow, R. F., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.194 · Cited by 224
Millan, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 221
Brain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205
“In contrast, a hyperglutamatergic hypothesis stems from evidence that 1) noncompetitive NMDA receptor antagonists increase extracellular glutamate levels in the prefrontal cortex, which generates an increase in the firing rate of cortical neurons (Moghaddam and Adams, 1998a; Lorrain et al., 2003; Jackson et al., 2004)…”
BackgroundKetamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Ali, F., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Nature Communications · doi:10.1038/s41467-019-13809-8 · Cited by 196
Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189
Xu, W., Morishita, W., Buckmaster, P. S., Pang, Z. P., Malenka, R. C., & Südhof, T. C. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.036 · Cited by 188
Carli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300893 · Cited by 187
López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183
The acute effects of NMDA antagonism: From the rodent to the human brain
Gunduz-Bruce, H. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.006 · Cited by 182
The neurobiology of methamphetamine induced psychosis
Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00537 · Cited by 178
Tan, H.-Y., Chen, Q., Sust, S., Buckholtz, J. W., Meyers, J. D., Egan, M. F., Mattay, V. S., Meyer-Lindenberg, A., Weinberger, D. R., & Callicott, J. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610125104 · Cited by 173
Ehrlichman, R. S., Gandal, M. J., Maxwell, C. R., Lazarewicz, M. T., Finkel, L. H., Contreras, D., Turetsky, B. I., & Siegel, S. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.031 · Cited by 171
Kargieman, L., Santana, N., Mengod, G., Celada, P., & Artigas, F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704848104 · Cited by 168
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Vallée, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052810 · Cited by 166
Karlsson, R.-M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., & Holmes, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.215 · Cited by 165
Distinct and Dynamic ON and OFF Neural Ensembles in the Prefrontal Cortex Code Social Exploration
Liang, B., Zhang, L., Barbera, G., Fang, W., Zhang, J., Chen, X., Chen, R., Li, Y., & Lin, D.-T. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.043 · Cited by 165
Del Arco, A., & Mora, F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.011 · Cited by 163
Bubser, M., Bridges, T. M., Dencker, D., Gould, R. W., Grannan, M., Noetzel, M. J., Lamsal, A., Niswender, C. M., Daniels, J. S., Poslusney, M. S., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500128b · Cited by 154
Edgar, J. C., Khan, S. Y., Blaskey, L., Chow, V. Y., Rey, M., Gaetz, W., Cannon, K. M., Monroe, J. F., Cornew, L., Qasmieh, S., et al. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1904-x · Cited by 153
“…likely associated with reduced GABA release onto pyramidal neurons, as a number of studies have demonstrated dysfunction of interneurons and elevated pyramidal cell activity following NMDAR blockade or knockout mice (Belforte et al. 2010; Jackson et al. 2004; Santana et al. 2011; Saunders et al.).”
Wood, J., Kim, Y., & Moghaddam, B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6377-11.2012 · Cited by 153
Self-citationDopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Arnsten, A. F. T., Wang, M., & Paspalas, C. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010512 · Cited by 149
Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M. H., Calhoun, V. D., D'Souza, D. C., Gueorguieva, R., He, G., Leung, H.-C., Ramani, R., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.170 · Cited by 148
“Second, WM networks are tuned by GABA interneurons (Arnsten, 2011; Rao et al, 2000) and there is evidence that NMDA-R antagonists, perhaps preferentially, impair GABA interneurons (Grunze et al, 1996; Homayoun and Moghaddam, 2007; Jackson et al, 2004; Maccaferri and Dingledine, 2002).”
BackgroundMolecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Wohleb, E. S., Gerhard, D., Thomas, A., & Duman, R. S. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160309114549 · Cited by 148
Hunt, M. J., Raynaud, B., & Garcia, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.020 · Cited by 146
Tseng, K. Y., Lewis, B. L., Hashimoto, T., Sesack, S. R., Kloc, M., Lewis, D. A., & O'Donnell, P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4166-08.2008 · Cited by 144
“…a well established pharmacological model of schizophrenia (Javitt and Zukin, 1991), increased glutamate levels (Moghaddam et al., 1997) and pyramidal cell firing (Jackson et al., 2004) in the PFC, likely attributable to blockade of NMDA receptors in interneurons (Homayoun and Moghaddam, 2007).”
BackgroundReview of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Li, X., Frye, M. A., & Shelton, R. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.198 · Cited by 144
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
Paz, R. D., Tardito, S., Atzori, M., & Tseng, K. Y. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.005 · Cited by 141
Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain
Lanté, F., Meunier, J., Guiramand, J., Maurice, T., Cavalier, M., de Jesus Ferreira, M.-C., Aimar, R., Cohen-Solal, C., Vignes, M., & Barbanel, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.027 · Cited by 140
Ketamine Disrupts Theta Modulation of Gamma in a Computer Model of Hippocampus
Neymotin, S. A., Lazarewicz, M. T., Sherif, M., Contreras, D., Finkel, L. H., & Lytton, W. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0501-11.2011 · Cited by 139
“Similar results have been obtained with related NMDAR psy-chotomimetics, phencyclidine and MK801 (Suzuki et al., 2002; Jackson et al., 2004).”
ResultReduced Early Auditory Evoked Gamma-Band Response in Patients with Schizophrenia
Leicht, G., Kirsch, V., Giegling, I., Karch, S., Hantschk, I., Möller, H., Pogarell, O. M., Hegerl, U., Rujescu, D., & Mulert, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.033 · Cited by 137
Homayoun, H., Jackson, M. E., & Moghaddam, B. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00875.2004 · Cited by 137
Self-citationGenetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 137
Razoux, F., Garcia, R., & Léna, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301057 · Cited by 135
Gamma oscillations in schizophrenia: Mechanisms and clinical significance
Sun, Y., Farzan, F., Barr, M. S., Kirihara, K., Fitzgerald, P. B., Light, G. A., & Daskalakis, Z. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.065 · Cited by 135
Davoudian, P. A., Shao, L.-X., & Kwan, A. C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00637 · Cited by 129
Labrie, V., & Roder, J. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.002 · Cited by 129
Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine
Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 123
Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Cavallari, M., Zappulla, C., Ulivieri, M., Napoletano, F., Capi, M., Corigliano, V., et al. (2015) · Scientific Reports · doi:10.1038/srep17799 · Cited by 121
A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia
Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.025 · Cited by 120
de la Salle, S., Choueiry, J., Shah, D., Bowers, H., McIntosh, J., Ilivitsky, V., & Knott, V. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00348 · Cited by 118
Lyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 118
Gozzi, A., Large, C. H., Schwarz, A. J., Bertani, S., Crestan, V., & Bifone, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301547 · Cited by 116
Godar, S. C., Fite, P. J., McFarlin, K. M., & Bortolato, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.001 · Cited by 113
Neural Synchrony in Schizophrenia: From Networks to New Treatments
Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm062 · Cited by 112
Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate
Robison, A. J., Thakkar, K. N., & Diwadkar, V. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.021 · Cited by 112
Lecourtier, L., Homayoun, H., Tamagnan, G. D., & Moghaddam, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.003 · Cited by 111
Self-citationSpatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110
“Acute systemic treatment with MK-801 in rats has been shown to preferentially block NMDARs on the medial prefrontal cortex (mPFC) GABAergic interneurons, leading to a reduction of GABAergic network function and a subsequent increase in pyramidal cell firing due to disinhibition.(11,12) Curiously, a local infusion of P…”
BackgroundThe role of the gut microbiome in the development of schizophrenia
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.010 · Cited by 110
Bygrave, A. M., Masiulis, S., Nicholson, E., Berkemann, M., Barkus, C., Sprengel, R., Harrison, P. J., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.44 · Cited by 109
Zhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107
Cortical Oscillations in Health and Disease
Traub, M., & Whittington, P. (2010) · doi:10.1093/acprof:oso/9780195342796.001.0001 · Cited by 107
Jones, N. C., Reddy, M., Anderson, P., Salzberg, M. R., O'Brien, T. J., & Pinault, D. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000848 · Cited by 107
The Medial Prefrontal and Orbitofrontal Cortices Differentially Regulate Dopamine System Function
Lodge, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.7 · Cited by 107
Karlsson, R., Tanaka, K., Heilig, M. A., & Holmes, A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.001 · Cited by 106
Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine
Cui, Y., Hu, S., & Hu, H. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.12.002 · Cited by 106
NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus
Zhang, Y., Yoshida, T., Katz, D. B., & Lisman, J. E. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00072.2012 · Cited by 105
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Savalia, N. K., Shao, L.-X., & Kwan, A. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.11.008 · Cited by 104
Goto, Y., & Grace, A. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.046 · Cited by 104
Amargós-Bosch, M., López-Gil, X., Artigas, F., & Adell, A. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005900 · Cited by 104
Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Inan, M., Petros, T. J., & Anderson, S. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 101
Patrizi, A., Picard, N., Simon, A. J., Gunner, G., Centofante, E., Andrews, N. A., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.018 · Cited by 100
“excitatory cortical circuits as previously reported (28,29).”
Iwata, Y., Nakajima, S., Suzuki, T., Keefe, R. S. E., Plitman, E., Chung, J. K., Caravaggio, F., Mimura, M., Graff‐Guerrero, A., & Uchida, H. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.68 · Cited by 97
Thakkar, K. N., Rösler, L., Wijnen, J. P., Boer, V. O., Klomp, D. W. J., Cahn, W., Kahn, R. S., & Neggers, S. F. W. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.007 · Cited by 96
Duncan, N. W., Wiebking, C., Tiret, B., Marjańska, M., Hayes, D. J., Lyttleton, O., Doyon, J., & Northoff, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060312 · Cited by 95
Large, C. H. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077712 · Cited by 94
Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer’s disease-like pathology
Sarkar, S., Engler-Chiurazzi, E. B., Cavendish, J. Z., Povroznik, J. M., Russell, A. E., Quintana, D. D., Mathers, P. H., & Simpkins, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146327 · Cited by 91
“In awake, behaving rodents, NMDA-R antagonists attenuate PFC neural activity associated with working memory maintenance, and NMDA-R antagonists impair working memory performance in both non-human primates and humans (Baron and Wenger, 2001; Ghoneim et al., 1985; Homayoun et al., 2004; Jackson et al., 2004; Krystal et…”
BackgroundNMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
Saunders, J. A., Gandal, M. J., & Siegel, S. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.049 · Cited by 90
Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models
Walker, A. G., Miller, B., Fritsch, J. N., Barton, S. J., & Rebec, G. V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2804-08.2008 · Cited by 90
Thomases, D. R., Cass, D. K., & Tseng, K. Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4147-12.2013 · Cited by 89
Metadata
- Authors
- Jackson, M. E., Homayoun, H., & Moghaddam, B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Moghaddam, Bita
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-05-24
- Volume
- 101
- Issue
- 22
- Pages
- 8467-8472
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC420417
- OpenAlex
- W2042422960
- Cited by
- 430
- References
- 53
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 15 · 2022: 11 · 2021: 16 · 2020: 19 · 2019: 22 · 2018: 16 · 2017: 17 · 2016: 21 · 2015: 29 · 2014: 18 · 2013: 23 · 2012: 28
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor hypofunction, NMDA receptor antagonists, prefrontal cortex, neuronal firing rate, working memory deficits, schizophrenia, frontal lobe dysfunction, behavioral stereotypy
- MeSH terms
- Action Potentials, Animals, Behavior, Dose-Response Relationship, Drug, Electrophysiology, Humans, Male, Synaptic Transmission, Neurons, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, Prefrontal Cortex, Excitatory Amino Acid Antagonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.